We are live on ! Find out more
NVCR icon

NovoCure
NVCR

200 hedge funds and large institutions have $3.06B invested in NovoCure in 2019 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 66 increasing their positions, 67 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

452% more call options, than puts

Call options by funds: $65.4M | Put options by funds: $11.8M

243% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 14

58% more capital invested

Capital invested by funds: $1.94B → $3.06B (+$1.12B)

20% more funds holding

Funds holding: 166 → 200 (+34)

4.52% more ownership

Funds ownership: 62.39% → 66.92% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

1% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 67

Holders
200
Holders Change
+34
Holders Change %
+20.48%
% of All Funds
4.33%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
48
Increased
66
Reduced
67
Closed
14
Calls
$65.4M
Puts
$11.8M
Net Calls
+$53.5M
Net Calls Change
+$26.7M

Top Buyers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$170M
2
Capital World Investors
Capital World Investors
California
+$108M
3
Renaissance Technologies
Renaissance Technologies
New York
+$37.8M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$29.6M
5
Two Sigma Investments
Two Sigma Investments
New York
+$22.6M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$36.2M
2
WRF
Waddell & Reed Financial
Kansas
-$33.1M
3
TA
Tamarack Advisers
California
-$22.4M
4
DCP
Darsana Capital Partners
New York
-$19.3M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
201
Hodges Capital Management
Texas
– -$2.53M -75,500 Closed
CI
202
Cambiar Investors
Colorado
– -$2.19M -65,479 Closed
MCM
203
McKinley Capital Management
Alaska
– -$771K -23,019 Closed
Walleye Trading
204
Walleye Trading
New York
– -$587K -12,193 Closed
Simplex Trading
205
Simplex Trading
Illinois
– -$349K -7,243 Closed
Parallax Volatility Advisers
206
Parallax Volatility Advisers
California
– -$103K -3,089 Closed
MWNA
207
Marshall Wace North America
New York
– -$96K -2,860 Closed
AIM
208
Advantage Investment Management
Iowa
– -$17K -500 Closed
LFG
209
Larson Financial Group
Missouri
– -$13K -376 Closed
ZB
210
Zions Bancorporation
Utah
– -$11K -321 Closed
GWM
211
Geneos Wealth Management
Colorado
– -$6K -200 Closed
ASN
212
Advisory Services Network
Georgia
– -$1K -26 Closed
WAM
213
Wealthspire Advisors (Maryland)
Maryland
– +$144 +3 New
WCM
214
WealthBridge Capital Management
Ohio
– +$289 +6 New
5 6 7 8
9

NVCR Hedge Fund Activity: Q1 2019 in Review

200 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q1 2019, worth a combined $3.06B — up 58% from $1.94B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new NVCR positions and 14 closed out — a net gain of 34 holders — while 66 added to existing stakes and 67 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $170M. The largest seller was Fidelity Investments, cutting an estimated $36.2M.

  • 200 institutional investors held NovoCure (NVCR) as of Q1 2019, up from 166 in Q4 2018.
  • Funds reported $3.06B of NovoCure stock for Q1 2019, up 58% quarter-over-quarter.
  • 48 funds opened new NovoCure positions in Q1 2019 and 14 closed out, a net change of +34 holders.
  • The largest NovoCure buyer in Q1 2019 was Baillie Gifford & Co, an estimated $170M added.
  • The largest NovoCure seller in Q1 2019 was Fidelity Investments, an estimated $36.2M sold.

Based on aggregated 13F filings for Q1 2019.